Lenz Therapeutics Inc (LENZ)

09:48 AM

Presbyopia Treatment Market Size in 7MM is expected to grow at - openPR.com

09:48 AM

Mar 31, 2025

18,900 Shares in LENZ Therapeutics, Inc. (NASDAQ:LENZ) Purchased by Swiss National Bank - Defense World

Mar 31, 2025

Mar 31, 2025

Swiss National Bank Takes $546,000 Position in LENZ Therapeutics, Inc. (NASDAQ:LENZ) - MarketBeat

Mar 31, 2025

Mar 27, 2025

LENZ Therapeutics Stock Is Attractive Before PDUFA (NASDAQ:LENZ) - Seeking Alpha

Mar 27, 2025

Mar 27, 2025

LENZ Therapeutics, Inc. (NASDAQ:LENZ) Shares Purchased by Charles Schwab Investment Management Inc. - Defense World

Mar 27, 2025

Mar 26, 2025

Bank of New York Mellon Corp Lowers Stock Position in LENZ Therapeutics, Inc. (NASDAQ:LENZ) - Defense World

Mar 26, 2025

Mar 24, 2025

Brokers Issue Forecasts for LENZ Q2 Earnings - Defense World

Mar 24, 2025

Mar 24, 2025

What is Leerink Partnrs’ Forecast for LENZ Q1 Earnings? - Defense World

Mar 24, 2025

Mar 24, 2025

Citigroup Increases LENZ Therapeutics (NASDAQ:LENZ) Price Target to $47.00 - MarketBeat

Mar 24, 2025

Mar 24, 2025

William Blair Issues Negative Outlook for LENZ Earnings - Defense World

Mar 24, 2025

Mar 23, 2025

LENZ Therapeutics (NASDAQ:LENZ) Price Target Raised to $47.00 - Defense World

Mar 23, 2025

Mar 22, 2025

Equities Analysts Offer Predictions for LENZ FY2026 Earnings - Defense World

Mar 22, 2025

Mar 22, 2025

What is HC Wainwright’s Estimate for LENZ Q1 Earnings? - Defense World

Mar 22, 2025

Mar 21, 2025

Lenz Therapeutics’ Earnings Call Highlights Positive Outlook - TipRanks

Mar 21, 2025

Mar 21, 2025

Promising Outlook for LENZ Therapeutics: Buy Rating Affirmed Amid Strong Market Position and Upcoming Product Launch - TipRanks

Mar 21, 2025

Mar 21, 2025

Brokerages Set LENZ Therapeutics, Inc. (NASDAQ:LENZ) PT at $35.40 - Defense World

Mar 21, 2025

Mar 20, 2025

Citi raises LENZ Therapeutics price target to $47, keeps Buy rating - Investing.com Australia

Mar 20, 2025

Mar 20, 2025

LENZ Therapeutics stock holds $38 target on FDA approval optimism By Investing.com - Investing.com Australia

Mar 20, 2025

Mar 20, 2025

LENZ Therapeutics stock holds $38 target on FDA approval optimism - Investing.com

Mar 20, 2025

Mar 20, 2025

Citi ups PT on LENZ Therapeutics on eye-drop approval confidence - TradingView

Mar 20, 2025

Mar 19, 2025

Lenz Therapeutics outlines Q4 2025 launch plans for LNZ100 amid FDA review progress - MSN

Mar 19, 2025

Mar 19, 2025

Earnings call transcript: LENZ Therapeutics Q4 2024 shows innovation drive - Investing.com India

Mar 19, 2025

Mar 19, 2025

Earnings call transcript: LENZ Therapeutics Q4 2024 shows innovation drive By Investing.com - Investing.com UK

Mar 19, 2025

Mar 19, 2025

LENZ Therapeutics, Inc. SEC 10-K Report - TradingView

Mar 19, 2025

Mar 19, 2025

LENZ THERAPEUTICS Earnings Results: $LENZ Reports Quarterly Earnings - Nasdaq

Mar 19, 2025

Mar 19, 2025

LENZ Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate Highlights - The Manila Times

Mar 19, 2025

Mar 19, 2025

LENZ Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Recent ... - The Bakersfield Californian

Mar 19, 2025

Mar 19, 2025

LENZ Therapeutics Secures FDA Decision Date with $209M War Chest for Presbyopia Drug Launch - StockTitan

Mar 19, 2025

Mar 19, 2025

LENZ Therapeutics (NASDAQ:LENZ) Now Covered by TD Cowen - Defense World

Mar 19, 2025

Mar 18, 2025

TD Cowen lifts LENZ Therapeutics stock to buy, sets $60 target - Investing.com Canada

Mar 18, 2025

Mar 18, 2025

TD Cowen lifts LENZ Therapeutics stock to buy, sets $60 target By Investing.com - Investing.com South Africa

Mar 18, 2025

Mar 18, 2025

TD Cowen Initiates LENZ Therapeutics at Buy With $60 Price Target -March 18, 2025 at 07:09 am EDT - Marketscreener.com

Mar 18, 2025

Mar 18, 2025

American Electric Power, Block and Lenz Therapeutics - TradingView

Mar 18, 2025

Mar 17, 2025

LENZ THERAPEUTICS Earnings Preview: Recent $LENZ Insider Trading, Hedge Fund Activity, and More - Nasdaq

Mar 17, 2025

Mar 11, 2025

LENZ Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate Highlights on March 19, 2025 - The Manila Times

Mar 11, 2025

Mar 11, 2025

LENZ Therapeutics Q4 Earnings: Key Updates Coming on Presbyopia Eye Drops - StockTitan

Mar 11, 2025

Mar 09, 2025

Rhumbline Advisers Boosts Stock Position in LENZ Therapeutics, Inc. (NASDAQ:LENZ) - Defense World

Mar 09, 2025

Mar 03, 2025

LENZ Therapeutics to Host Commercial Day on April 15, 2025 - The Manila Times

Mar 03, 2025

Mar 03, 2025

Will LENZ's Presbyopia Eye Drop Disrupt the Vision Care Market? Commercial Strategy Reveal Coming - StockTitan

Mar 03, 2025

Feb 25, 2025

Insiders Enjoy US$227k Return After Buying LENZ Therapeutics Stock - Simply Wall St

Feb 25, 2025

Feb 24, 2025

LENZ Therapeutics to Participate in Upcoming Investor Conferences - The Manila Times

Feb 24, 2025

Feb 24, 2025

LENZ Therapeutics to Present at Upcoming Investor Conferences in March 2025 - Nasdaq

Feb 24, 2025

Feb 24, 2025

Can LENZ's Novel Presbyopia Treatment Disrupt the $8B Eye Care Market? Key Investor Presentations Coming - StockTitan

Feb 24, 2025

Feb 23, 2025

Myopia And Presbyopia Eye Drops Market Future Business - openPR

Feb 23, 2025

Feb 21, 2025

LENZ Therapeutics (LENZ) to Release Quarterly Earnings on Wednesday - Defense World

Feb 21, 2025

Feb 19, 2025

LENZ Therapeutics Insiders Placed Bullish Bets Worth US$551.1k - Yahoo Finance UK

Feb 19, 2025

Feb 18, 2025

Citi maintains Buy on LENZ Therapeutics, target at $44 By Investing.com - Investing.com Canada

Feb 18, 2025

Feb 18, 2025

Citi maintains Buy on LENZ Therapeutics, target at $44 - Investing.com

Feb 18, 2025